Research published today shapes medical treatment, infrastructure decisions, legislation, and the datasets training the next generation of AI. When something false enters the record, the damage compounds for years before anyone catches it.
Scribe turns peer review from a manual judgment call into a context-backed decision. Instead of relying on individual reviewers to catch what they cannot see, Scribe equips them with verified citation data, claim-level evidence, and integrity signals before they read a single line. Reviewer time goes down. Detection quality goes up.
The surge in AI-generated submissions has outpaced every tool journals have. Peer reviewers cannot catch what they cannot see. And the consequences compound.
Five sequential ML stages analyze every citation, every claim, and every assertion against the open scientific literature. Scribe gives reviewers the context their judgment needs.
Below is a simulated view of Scribe working alongside a peer reviewer in real time: paper on the left, Scribe report in the center, reviewer writing notes on the right.
Nanoparticle-mediated drug delivery in glioblastoma: a systematic review
Submitted · Journal of Neuro-Oncology · 2025
Recent studies demonstrate that nanoparticle carriers achieve 94% blood-brain barrier penetration rates in vivo, representing a significant therapeutic advance over conventional approaches. Smith et al. (2023) established the definitive therapeutic window for temozolomide encapsulation at 40-60nm particle diameter, a finding corroborated by six independent meta-analyses. Furthermore, no published study has reported adverse hippocampal tissue accumulation at doses below 5mg/kg. The blood-brain barrier presents unique challenges for chemotherapeutic delivery that nanoparticle engineering has increasingly addressed through surface modification strategies.Scribe does not replace reviewers. It removes the invisible burden: finding what is missing, checking what cannot be manually verified, and surfacing what the submission chose not to tell you.
Scribe is running a pilot with a small number of academic journals. Drop your email and phone number and we will be in touch.
Insights on the replication crisis, AI-generated research, and what happens when the record breaks down.